- $77.28m
- $193.01m
- $311.60m
- 50
- 68
- 40
- 53
Annual income statement for Quantum, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | R2022 March 31st | R2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 403 | 350 | 383 | 422 | 312 |
| Cost of Revenue | |||||
| Gross Profit | 173 | 151 | 158 | 143 | 125 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 382 | 356 | 392 | 440 | 340 |
| Operating Profit | 21.2 | -6.39 | -8.2 | -18.1 | -28.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -4.41 | -35.2 | 39.7 | -16.4 | -40.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -5.21 | -35.5 | 38.4 | -18.4 | -41.3 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -5.21 | -35.5 | 38.4 | -18.4 | -41.3 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -5.21 | -35.5 | -21.4 | -18.4 | -41.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.42 | -10.9 | -5.36 | -3.63 | -8.24 |